Advanced search
Publication Cover
Current Eye Research Volume 36, 2011 - Issue 4
Submit an article Journal homepage
241
Views
35
CrossRef citations to date
0
Altmetric
Original Article

VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans

Vivian BarakImmunology Laboratory for Tumor Diagnosis, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
,
Jacob Pe’erDepartment of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, IsraelCorrespondence[email protected]
,
Inna KalickmanImmunology Laboratory for Tumor Diagnosis, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
&
Shahar FrenkelDepartment of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Pages 386-390 | Received 08 Apr 2010, Accepted 10 Oct 2010, Published online: 01 Feb 2011

REFERENCES

  • Scotto J, Fraumeni Jr. JF, Lee JA. Melanomas of the eye and other noncutaneous sites: Epidemiologic aspects. J Natl Cancer Inst. 1976;56:489–491.
  • Diener-West M, Reynolds SM, Agugliaro DJ, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group, Report No. 26. Arch Ophthalmol. 2005;123:1639–1643.
  • The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors. COMS Report No. 28. Arch Ophthalmol. 2006;124:1684–1693.
  • Jensen OA. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943–1952. Acta Ophthalmol (Copenh). 1982;60:161–182.
  • Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. II: Characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch Ophthalmol. 2001;119:951–965.
  • Frenkel S, Nir I, Hendler K, et al. Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol. 2009;93:1042–1046.
  • Kadkol SS, Lin AY, Barak V, et al. Osteopontin expression and serum levels in metastatic uveal melanoma: A pilot study. Invest Ophthalmol Vis Sci. 2006;47:802–806.
  • Barak V, Frenkel S, Kalickman I, et al. Serum markers to detect metastatic uveal melanoma. Anticancer Res. 2007;27:1897–1900.
  • Sahin A, Kiratli H, Tezel GG, et al. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas. Ophthalmic Res. 2007;39:40–44.
  • Missotten GS, Notting IC, Schlingemann RO, et al. Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol. 2006;124:1428–1434.
  • Lin AY, Maniotis AJ, Valyi-Nagy K, et al. Distinguishing fibrovascular septa from vasculogenic mimicry patterns. Arch Pathol Lab Med. 2005;129:884–892.
  • El Filali M, Missotten GS, Maat W, et al. Regulation of VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci. 2009 Dec 30. [Epub ahead of print].
  • Bates DO, Cui TG, Doughty JM, et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 2002;62:4123–4131.
  • Rennel E, Waine E, Guan H, et al. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. Br J Cancer. 2008;98:1250–1257.
  • Rennel ES, Varey AH, Churchill AJ, et al. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br J Cancer. 2009;101:1183–1193.
  • Karen Hendler, Jacob Pe’er, Igor Kaiserman, Ronen Baruch, Inna Kalickman, Vivian Barak, Shahar Frenkel A. Comparison with serum biomarkers in metastatic uveal melanoma. Anticancer Research, 2011 (in press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.